Genesis Molecular AI Unveils Pearl: First Generative Foundation Model to Surpass AlphaFold 3 in Drug-Protein Binding Prediction
Genesis Molecular AI, the company pioneering the world’s leading molecular AI models for drug design and development, has unveiled Pearl, a generative foundation model for biomolecular structure prediction. According to new research co-authored with experts from NVIDIA, Pearl outperforms all existing models — including AlphaFold 3 — in predicting how small molecules bind to proteins, a long-standing challenge in biochemistry and pharmaceutical R&D.
